Long-term data from the pivotal phase 3 ELARA trial showed durable efficacy with tisagenlecleucel in high-risk follicular ...

Currently, prognosis in patients with FL is assessed using clinical scores such as the Follicular Lymphoma International ... 6 After adjusting for the FLIPI score, the researchers found that ...

Follicular Lymphoma International Prognostic Index (FLIPI) and tumor burden, as judged by the GELF score, are each in use for risk stratification. A period of observation at diagnosis may be ...

The combination of loncastuximab tesirine (Zynlonta) and rituximab achieved promising response rates in patients with ...